Loading the section…
The price of Alzamend Neuro, Inc. (ALZN) on October 9, 2026 is 1.34 USD, 0.00% on the day. Over 52 weeks the stock traded between 0.8400 USD and 2.68 USD; the price now sits 27% of the way up that range. Over the past year the price changed by −47.04%. Market capitalization is 534,444 USD, rank 369 among 373 stocks of the same industry with a known capitalization.
Closing prices for 9 October 2026
Next earnings report: none scheduled in the next five weeks · Earnings calendar
Change over the period shown (line colour): −39.09 %
Alzamend Neuro, Inc. trades on Nasdaq under the ticker ALZN. The company belongs to the Health care sector. The trading history on this page starts on 15 June 2021.
Over the past 52 weeks ALZN has traded between 0.8400 $ and 2.68 $. As of 9 October 2026 the price stood 27.17 % of the way from the 52-week low to the high.
Over one year ALZN shares fell 47.04 %; over six months they rose 56.18 %. Volatility over 90 days is 72.06 %. Dividends are not included: this is price change only, as of 9 October 2026.
The company reported a loss over the last four quarters, so a price-to-earnings ratio is not calculated. Price to book is 0.1, below the sector median of 2.5. Calculated from reports for the period ending 31 October 2025.
| Date | Open | High | Low | Close | Volume, shares |
|---|---|---|---|---|---|
| 9 October 2026 | 1.43 | 1.43 | 1.34 | 1.34 | 13,300 |
| 8 October 2026 | 1.32 | 1.35 | 1.22 | 1.34 | 7,000 |
| 7 October 2026 | 1.37 | 1.42 | 1.34 | 1.37 | 18,800 |
| 6 October 2026 | 1.44 | 1.44 |
The series is stated in the current share scale after splits; dividends are not included in the price
Based on the last 12 months of reports, through 31 October 2025
The sector median covers every company in the sector on the US market, loss-making ones included.
Address:480 PEACHTREE ROAD NE, SECOND FLOOR SUITE 103, ATLANTA, GA, 30326, US
ALZN has a return on equity of −134.48 %, below the sector median of −41.68 %. Return on assets is −115.53 %, below the sector median of −32.11 %.
| 1.2B |
| PFEPfizer, Inc. | 28.28 | +1.65 % | 922M |
| ABTAbbott Laboratories | 99.60 | +1.13 % | 921M |
| BMYBristol-Myers Squibb Company | 59.12 | −0.77 % | 714M |
| REGNRegeneron Pharmaceuticals, Inc. | 746.54 | +0.94 % | 555M |
| 1.34 |
| 1.37 |
| 32,100 |
| 5 October 2026 | 1.38 | 1.48 | 1.38 | 1.41 | 25,400 |
| 2 October 2026 | 1.41 | 1.48 | 1.20 | 1.37 | 236,400 |
| 1 October 2026 | 1.72 | 1.72 | 1.26 | 1.32 | 150,600 |
| 30 September 2026 | 1.84 | 1.84 | 1.73 | 1.73 | 21,700 |
| 29 September 2026 | 1.75 | 1.85 | 1.74 | 1.82 | 49,500 |
| 28 September 2026 | 1.80 | 1.92 | 1.73 | 1.73 | 83,800 |
| 25 September 2026 | 1.90 | 1.90 | 1.76 | 1.83 | 23,300 |
| 24 September 2026 | 1.90 | 1.93 | 1.82 | 1.82 | 150,500 |
| 23 September 2026 | 1.93 | 1.95 | 1.93 | 1.94 | 45,800 |
| 22 September 2026 | 1.93 | 1.94 | 1.90 | 1.94 | 91,200 |
| 21 September 2026 | 1.89 | 1.94 | 1.87 | 1.94 | 206,700 |
| 18 September 2026 | 1.84 | 1.89 | 1.81 | 1.89 | 240,700 |
| 17 September 2026 | 1.83 | 1.84 | 1.82 | 1.84 | 42,700 |
| 16 September 2026 | 1.79 | 1.85 | 1.79 | 1.83 | 167,600 |
| 15 September 2026 | 1.75 | 1.79 | 1.73 | 1.78 | 230,000 |
| 14 September 2026 | 1.72 | 1.76 | 1.71 | 1.75 | 69,100 |